Oxytocin alleviates cisplatin-induced renal damage in rats

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 127

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-17-10_004

تاریخ نمایه سازی: 4 آبان 1400

Abstract:

Objective(s):The purpose of the present study was to investigate the protective effect of oxytocin on cisplatin (CP)-induced renal damage in rats. Materials and Methods: Fourteen adult Sprague Dawley rats, weighing ۲۰۰ to ۲۱۰, were administered by cisplatin (CP, ۲ mg/kg/day) twice a week for five weeks. Then, they were randomly divided into two groups and treated with either saline (۱ ml/kg/day) or OT                       (۲۰۰ µg/kg/day) for five weeks. Seven rats served as control group. At the end of the treatment period, animals were sacrificed and their kidneys were assessed histologically. In addition,            C-reactive protein (CRP), TGF-β and Akt expression were evaluated immunohistochemically. Results:Both tubules and glomeruli were found to be severely damaged with marked medullary tubulo-interstitial inflammation due to chronic cisplatin exposure, particularly in the saline-treated group (Group ۱) compared to control group. Oxytocin treatment spared renal tissue significantly by suppressing CRP and TGF-β, and enhancing Akt expression. Conclusion: We conclude that renal damage due to cisplatin toxicity was prevented to a great extent by the anti-inflammatory effect of oxytocin.   

Authors

Oytun Erbas

Gaziosmanpasa University Faculty of Medicine, Department of Physiology, Tokat Turkey

Huseyin Anil Korkmaz

Izmir Dr Behcet Uz Pediatric Medicine and Surgery Training and Research Hospital, Pediatric Endocrinology Clinic, Izmir, Turkey

Fatih Oltulu

Ege University School of Medicine, Department of Histology and Embryology, Izmir, Turkey

Hüseyin Aktug

Ege University School of Medicine, Department of Histology and Embryology, Izmir, Turkey

Altug Yavasoglu

Ege University School of Medicine, Department of Histology and Embryology, Izmir, Turkey

Levent Akman

Ege University School of Medicine, Department of Gynecology and Obstetrics, Izmir, Turkey

Volkan Solmaz

Gaziosmanpasa University Faculty of Medicine, Department of Neurology, Tokat, Turkey

Dilek Taskiran

Ege University Faculty of Medicine, Department of Physiology, Izmir, Turkey

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with ...
  • Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. ...
  • Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. ...
  • Tikoo K, Bhatt DK, Gaikwad AB, Sharma V, Kabra DG. ...
  • Jordan P, Carma-Fonseca M. Molecular mechanism involved in cisplatin cytotoxicity. ...
  • Sadzaku Y, Shoji T, Takino Y. Mechanism of the increase ...
  • Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress ...
  • Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates ...
  • Pabla N, Dong Z. Cispaltin nephrotoxicity: mechanism and renoprotective strategies. ...
  • Ramesh G, Reeves WB. Salicylate reduces cisplatin nephrotoxicity by inhibition ...
  • ۱۱.Yamate J, Sato K, Ide M, Nakanishi M, Kuwamura M, ...
  • Yamate J, Machida Y, Ide M, Kuwamura M, Sawamoto O, ...
  • Olson BR, Hoffman GE, Sved AF, Stricker EM, Verbalis JG. ...
  • Yazawa H, Hirasawa A, Horie K, Saita Y, Iida E, ...
  • Jankowski M, Wang D, Hajjar F, Mukaddam-Daher S, McCann SM, ...
  • Gutkowska J, Jankowski M. Oxytocin: old hormone, new drug. Pharmaceuticals ...
  • Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, ...
  • Rashed LA, Hashem RM, Soliman HM. Oxytocin inhibits NADPH oxidase ...
  • Erbas O, Ergenoglu AM, Akdemir A, Yeniel AO, Taskiran D. ...
  • Erbas O, Oltulu F, Taskiran D. Amelioration of rotenone-induced dopaminergic ...
  • Erdogan H, Fadillioğlu E, Kotuk M, Iraz M, Tasdemir S, ...
  • Ashrafi F, Nematbakhsh M, Safari T, Talebi A, Nasri H, ...
  • Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: ...
  • Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanism in proximal tubule cell. ...
  • Yang J, Liu Y. Dissection of key events in tubular ...
  • Pick E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke ...
  • Bottinger EP, Bitzer M. TGF- alpha signaling in renal disease. ...
  • Oldfield MD, Bach LS, Forbes JM, Nikolic-Pateerson D, McRobert A, ...
  • Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, ...
  • Huang XR, Li JH, Chen YX, Johnson RJ, Lan HY. ...
  • Li JH, Zhu HJ, Huang XR. Smad۷ inhibits fibrotic effect ...
  • Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. ...
  • Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong ...
  • Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, ...
  • Padilla ND, Bleeker WK, Lubbers Y, Rigter GM, Van Mierlo ...
  • Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. ...
  • Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. ...
  • Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at ...
  • نمایش کامل مراجع